Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ovarian cancer
Pharma
China approves 4 new drugs, including global 1st-in-class
China has granted the world's first approval for an HDAC/PI3K dual-targeted inhibitor.
Angus Liu
Jul 2, 2025 11:32am
Keytruda delivers trial win in some patients with ovarian cancer
May 15, 2025 10:56am
FDA approves Verastem's combo for rare form of ovarian cancer
May 9, 2025 10:42am
GSK trial result mirrors Merck's problem in ovarian cancer
Dec 20, 2024 10:46am
Keytruda-Lynparza combo scores tepid win in ovarian cancer trial
Dec 9, 2024 11:18am
In 3rd bankruptcy bid, J&J sweetens talc settlement offer to $8B
Sep 23, 2024 9:33am
